These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1709613)

  • 21. Diclofenac binding to human polymorphonuclear neutrophils: effect on respiratory burst and N-formylated peptide binding.
    Perianin A; Gougerot-Pocidalo MA; Giroud JP; Hakim J
    Biochem Pharmacol; 1987 Aug; 36(16):2609-15. PubMed ID: 3300657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction in human alveolar macrophages: diminished chemotactic response to FMLP correlates with a diminished density of Gi proteins and FMLP receptors.
    Beaty CD; Martin TR; Wilson CB
    Am J Respir Cell Mol Biol; 1991 Jul; 5(1):87-92. PubMed ID: 1908689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and purification of recombinant human N-formyl-L-leucyl-L-phenylalanine (FMLP) receptor: generation of polyclonal antibody against FMLP receptor.
    Lala A; Sojar HT; De Nardin E
    Biochem Pharmacol; 1997 Aug; 54(3):381-90. PubMed ID: 9278097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional characterization of the human formyl peptide receptor ligand-binding region.
    Radel SJ; Genco RJ; De Nardin E
    Infect Immun; 1994 May; 62(5):1726-32. PubMed ID: 8168934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal or oxidation of surface membrane sialic acid inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong RR; Elfman F
    J Immunol; 1985 Mar; 134(3):1902-8. PubMed ID: 2981927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).
    Anton P; O'Connell J; O'Connell D; Whitaker L; O'Sullivan GC; Collins JK; Shanahan F
    Gut; 1998 Mar; 42(3):374-9. PubMed ID: 9577344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J; Hoff SF
    Gen Pharmacol; 1989; 20(3):329-34. PubMed ID: 2545509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody modulates human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine (fMLP).
    McNeely MC; Lawley TJ; Harvath L
    J Invest Dermatol; 1993 Sep; 101(3):377-82. PubMed ID: 8396610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the human fMLP receptor in neutrophils and in Xenopus oocytes.
    Wittmann S; Fröhlich D; Daniels S
    Br J Pharmacol; 2002 Mar; 135(6):1375-82. PubMed ID: 11906950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.
    Paclet MH; Davis C; Kotsonis P; Godovac-Zimmermann J; Segal AW; Dekker LV
    Biochem J; 2004 Jan; 377(Pt 2):469-77. PubMed ID: 14556648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
    Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
    J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils.
    Psychoyos S; Smith CW
    Agents Actions; 1989 Mar; 26(3-4):372-7. PubMed ID: 2735228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
    Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
    J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an IgA inhibitor of neutrophil chemotaxis and its membrane target for the metabolic burst.
    Moy JN; Nelson RD; Richards KL; Hostetter MK
    Immunology; 1990 Feb; 69(2):257-63. PubMed ID: 2407643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of formyl peptide receptor binding to rabbit neutrophil plasma membranes. Use of monovalent cations, guanine nucleotides, and bacterial toxins to discriminate among different states of the receptor.
    Feltner DE; Marasco WA
    J Immunol; 1989 Jun; 142(11):3963-70. PubMed ID: 2715641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary linoleate supplementation modulates formyl-peptide receptor expression and functional responses of rat neutrophils.
    Gyllenhammar H; Hafström I; Borgeat P; Ringertz B; Becker W; Svensson J; Palmblad J
    J Lab Clin Med; 1990 Apr; 115(4):487-96. PubMed ID: 2157784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of receptors and digestive activity toward synthesized formyl-chemotactic peptide in human polymorphonuclear leukocytes.
    Nunoi H; Endo F; Chikazawa S; Matsuda I
    Blood; 1985 Jul; 66(1):106-14. PubMed ID: 2988664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor.
    English D; Broxmeyer HE; Gabig TG; Akard LP; Williams DE; Hoffman R
    J Immunol; 1988 Oct; 141(7):2400-6. PubMed ID: 3049807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X; Roy C; Fernandes MJ; Marceau F
    Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.